Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype
2007 Standout
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
MALE BREAST CANCER
1998
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Tamoxifen, serum lipoproteins and cardiovascular risk
1988
Successful use of letrozole in male breast cancer: A case report and review of hormonal therapy for male breast cancer
2005
Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology.
1992 Standout
Breast cancer
2016 Standout
pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
1991 Standout
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Preparation of human metabolites of propranolol using laboratory‐evolved bacterial cytochromes P450
2005 StandoutNobel
Morphological Changes Induced by 6-Month Treatment of Intact and Ovariectomized Mice with Tamoxifen and the Pure Antiestrogen EM-800
1997
Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer
1990
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Tamoxifen for the prevention of breast cancer
2000
Recovering three-dimensional shape around a corner using ultrafast time-of-flight imaging
2012 StandoutNobel
Pharmacological Characterization of 4-hydroxy-N-desmethyl Tamoxifen, a Novel Active Metabolite of Tamoxifen
2004
An update on male breast cancer and future directions for research and treatment
2013
Prevention of VTE in Nonsurgical Patients
2012 Standout
Interval between symptom onset and diagnosis of pediatric solid tumors
1991
A Panel of Cytochrome P450 BM3 Variants to Produce Drug Metabolites and Diversify Lead Compounds
2009 StandoutNobel
Carcinoma of the Male Breast
1992
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Tamoxifen in the Treatment of Breast Cancer
1988
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Male breast cancer
2006 Standout
Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice
1997
Polyphenols: food sources and bioavailability
2004 Standout
Prevention of Venous Thromboembolism
2004 Standout
Male Breast Cancer Report of a Series of 50 Cases
1994
Male Breast Carcinoma: II. A study of the total material reported to the Swedish Cancer Registry 1958--1967 with respect to treatment, prognostic factors and survival
1987
Induction of gene encoding FABP4 in Pten‐null keratinocytes
2009 StandoutNobel
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays
1990
Prevention of Venous Thromboembolism
2008 Standout
Constructive and unconstructive repetitive thought.
2008 Standout
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Production and Actions of Estrogens
2002 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Image transmission through an opaque material
2010 Standout
Importance of estrogen sulfates in breast cancer
1989
Racial differences in breast carcinoma survival
2000
A retrospective study of male breast cancer in Holland
1985
Cancer of the Breast
1980
The pharmacology and clinical uses of tamoxifen
1984
Optical Coherence Tomography
1991 StandoutScience
Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation
1983 StandoutNatureNobel
Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model
1980
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Ruminative Response Styles and Delay of Seeking Diagnosis for Breast Cancer Symptoms
2006
Distinct roles of PTCH2 splice variants in Hedgehog signalling
2004
Tamoxifen (Nolvadex) for premenopausal patients with advanced breast cancer
1984
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
A new clinical index of growth rate in the staging of breast cancer
1980
Hormonal Therapy for Metastatic Male Breast Cancer
1983
Race and socio-economic status in survival from breast cancer
1982
Social class and black-white differences in breast cancer survival.
1986
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
1992 Standout
Smoothened Signal Transduction Is Promoted by G Protein-Coupled Receptor Kinase 2
2006 StandoutNobel
Mechanisms of Estrogen Action
2001 Standout
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
The importance of dose intensity in chemotherapy of metastatic breast cancer.
1984 Standout
Health Differentials between Blacks and Whites: Recent Trends in Mortality and Morbidity
1987
The Will Rogers Phenomenon
1985 Standout
The sex hormone profile of male patients with breast cancer
1983
Non-steroidal antioestrogens—Receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells
1984
Testing Theoretical Explanations of Intention to Seek Care for a Breast Cancer Symptom1
1991
Habit and intention in everyday life: The multiple processes by which past behavior predicts future behavior.
1998 Standout
Indian hedgehog and β-catenin signaling: Role in the sebaceous lineage of normal and neoplastic mammalian epidermis
2003
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare
1984
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
2012 Standout
High-affinity anti-oestrogen binding site distinct from the oestrogen receptor
1980 Nature
Male breast cancer: a 13-year review of 89 patients.
1984
Bone metastases and breast cancer
1985
A prognostic index in primary breast cancer
1982
Rethinking Rumination
2008 Standout
Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies
2002 Standout
Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen
1984
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
Tamoxifen in the treatment of male breast carcinoma
1983
Aromatization by Skeletal Muscle
1986
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
Selective Estrogen Receptor Modulators: Clinical Spectrum*
1999
Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative Trial
2004
Actual Causes of Death in the United States
1993 Standout
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2005 Standout
Ballistic 2-D Imaging Through Scattering Walls Using an Ultrafast Optical Kerr Gate
1991 Science
Breast Cancer in Men
2002 Standout
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Terawatt to Petawatt Subpicosecond Lasers
1994 StandoutScienceNobel
Works of John Patterson being referenced
Tamoxifen in advanced breast cancer
1978
GLI1 Localization in the Germinal Epithelial Cells Alternates Between Cytoplasm and Nucleus: Upregulation in Transgenic Mice Blocks Spermatogenesis in Pachytene1
2001
Clinical pharmacology of tamoxifen and N-desmethyltamoxifen in patients with advanced breast cancer
1980
Delay, stage of disease and survival from breast cancer
1979
Tamoxifen (Nolvadex) therapy ? Radionale for loading dose followed by maintenance dose for patients with metastatic breast cancer
1982
The biology and physiology of ‘Nolvadex’ (tamoxifen) in the treatment of breast cancer
1982
Serum concentrations of tamoxifen and major metabolite during long-term nolvadex therapy, correlated with clinical response.
1980
Six‐year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer
1985
Use of tamoxifen in advanced male breast cancer.
1981
Studies on the metabolism and pharmacokinetics of tamoxifen in normal volunteers.
1981